trending Market Intelligence /marketintelligence/en/news-insights/trending/QIudGb-Z9GlsnvwMin2S5A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

ResTORbio plans $50M common stock offering

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

ResTORbio plans $50M common stock offering

Biopharmaceutical company resTORbio Inc. started an underwritten public offering of $50 million of its common shares.

Underwriters will have an option to buy up to an additional 15% of shares in the public offering to cover overallotments.

BofA Merrill Lynch, SVB Leerink and Guggenheim Securities are acting as joint book-running managers with Wedbush PacGrow acting as co-manager for the proposed offering.

Boston-based resTORbio develops and sells novel therapeutics to treat aging-related diseases.